INTRODUCTION
Systemic lupus erythematosus (SLE)l has long been considered a prototypic autoimmune disease because of its association with B cell hyperactivity (1, 2), resulting in production of multiple autoantibodies, and with disorders of cell-mediated immunity (3, 4) . Previous studies have suggested that many ofthese abnormalities Dr. Morimoto is a recipient of a postdoctoral fellowship award from the Arthritis Foundation. Address reprint requests to Dr. Chikao Morimoto, Division of Tumor Immunology, Sidney Farber Cancer Institute, Boston, Mass. 02115.
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occur as a consequence of defects in suppressor T cell function (5) (6) (7) (8) (9) . To determine whether imbalance among subsets of human T cells exists in patients with SLE, we analyzed peripheral blood lymphocytes in SLE patients during active and inactive stages of disease. For this analysis, we used monoclonal antibodies to cell surface antigens restricted to inducer (T4) and suppressor (T5/T8) T cell subsets, as well as to a common T cell antigen (T3) defining all peripheral T cells (10) (11) (12) (13) (14) . The results show that the T5/T8 suppressor subset is selectively decreased during active disease and is reconstituted after the cessation of disease activity. METHODS Isolation oflymphocytes. Human peripheral blood mononuclear cells were isolated from heparinized venous blood by Ficoll-Hypaque (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) density centrifugation.
Production of monoclonal antibodies and analysis of lymphocyte populations with a fluorescence-activated cell sorter. Four monoclonal antibodies, termed anti-T3, anti-T4, anti-T5, and anti-T8, were used in the present study. The production and characterization have been described elsewhere (10) (11) (12) (13) (14) . In brief, anti-T4 was shown to react with 55-60% of peripheral T cells, representing the human inducer population (11, 12) , whereas anti-T5 and anti-T8 defined -20-30% of T cells with cytotoxic/suppressor functions (13, 14) . A monoclonal antibody, termed anti-T3 and reactive with 100% of peripheral T cells, was used to enumerate T cells (10 (Tables I and II) . First, there was an absolute diminution in the total T cell population. Second, the most striking abnormality was the decreased number of the T5+/T8+ T cell subset. Interestingly, a patient with hydralazine-induced active SLE (case 2) also showed a markedly decreased number of the T5+/T8+ subsets (Table II) (Fig. 1B) . In contrast, 4 wk later, with marked reduction in disease activity, there was a return of the T8+ subset (Fig. 1C) It still remains to be determined whether the loss of this major immunoregulatory T cell subset is primary or secondary to the pathophysiologic process in SLE; however, the observation that patients with druginduced SLE can demonstrate the same cellular defect as naturally occurring SLE, namely loss of T5+/T8+ T cells, suggests that aberrations in these subsets may be critical for pathogenesis. In addition, it implies that drug-induced, as xvell as naturally occurring immunopathologic states may initiate immunoregulatory aberrations that could result in similar clinical disease.
